Shukra Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | BSE: 524632
₹20.17 
-0.41 (-1.99 %)
Last Updated: 04 Apr 2025 04:01 PM
BEARISH
Overview
Open (₹) 20.17
High (₹) 20.17
Low (₹) 20.17
Prev. Close (₹) 20.58
Volume 18,876
VWAP (₹) 230.64
ROCE (%) 31.66
Industry P/E 46.49
TTM P/E 106.16
P/B Ratio 0.38
Market Cap (₹) Cr.883.20
Dividend Yield (%)4.96
EPS (₹) 16.93
ROE32.16%
Sales Growth (%) 26.75
Profit Growth (%)320.68
Day Range
20.1720.17
52 Week Range
5.7527.15
Historical Returns
Returns (6M)
186.1 %
Returns (1Y)
162.29 %
Returns (3Y)
6012.12 %
Returns (5Y)
8669.57 %
Returns (6M)
186.1 %
Returns (1Y)
162.29 %
Returns (3Y)
6012.12 %
Returns (5Y)
8669.57 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Positive ROC (9) indicates upward momentum.
Technicals
Technical Rating
BEARISHRSI 66.07
MFI 86.83
ATR 7.96
Commodity Channel Index 76.22
ROC125 263.05
ROC21 0.64
Williams %R -0.29
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 242.50 | 250.00 | 264.85 | 227.65 | 220.15 | 205.30 | 197.80 |
| Week Ago | 193.55 | 193.55 | 193.55 | 193.55 | 193.55 | 193.55 | 193.55 |
| Month Ago | 224.50 | 224.50 | 224.50 | 224.50 | 224.50 | 224.50 | 224.50 |
EMA & SMA
20.17
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 207.06
9 Day 207.29
10 Day 207.99
12 Day 211.25
14 Day 210.93
20 Day 217.69
26 Day 219.29
50 Day 186.37
100 Day 127.76
200 Day 108.00
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 Jan, 2025 | Stock split from Rs. 10/- to Re. 1/-. | 21 Mar, 2025 | 21 Mar, 2025 |
| 29 May, 2024 | Rs.1.0000 per share(10%)Final Dividend | 23 Sept, 2024 | 01 Jan, 1970 |
| 29 Feb, 2024 | Bonus issue in the ratio of 3:1 of Rs. 10/-. | 19 Apr, 2024 | 20 Apr, 2024 |
| 29 May, 2023 | Rs.0.5000 per share(5%)Final Dividend | 15 Sept, 2023 | 01 Jan, 1970 |
| 25 Aug, 2022 | Rights issue of equity shares of Rs. 10/- in the ratio of 6:1 @ premium of Rs. 10/-. | 02 Feb, 2023 | 02 Feb, 2023 |
| 30 May, 2022 | Rs.0.5000 per share(5%)Final Dividend | 22 Sept, 2022 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 29 Mar, 2025 | BSE India | Intimation of change in Secretarial Auditor of the company |
| 26 Mar, 2025 | BSE India | Outcome of the meeting of Independent directors held on today to consider the agendas as attached. |
| 20 Mar, 2025 | BSE India | Intimation for notice received from BSE for new ISIN |
| 18 Mar, 2025 | BSE India | Submission of Activation letter received from the National Securities Depository Limited and Central Depository Services (India) Limited for stock split of shares. |
| 17 Mar, 2025 | BSE India | Intimation of New ISIN for stock split for the record date 21st March, 2025. |
| 07 Mar, 2025 | BSE India | This is to inform you that Friday, 21st March, 2025 has been fixed as the Record Date. |
| 07 Mar, 2025 | BSE India | Voting result of Postal Ballot under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. |
| 14 Feb, 2025 | BSE India | Submission Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31st December, 2024 |
| 14 Feb, 2025 | BSE India | Considered and approved Un-audited Financial Results of the Company along with Limited Review Report for the quarter and Nine Months ended on 31st December, 2024. |
| 14 Feb, 2025 | BSE India | Outcome of Board Meeting held today i.e. on 14th February, 2025 and 1. submission of Un-audited Financial Results of the Company for the Quarter and Nine months ended on 31st December, 2024.\r\n2. Appointment Mr. Jay Gandhi, as Internal Auditor for FY 2024-25, The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is attached as 'Annexure A'.\r\n3. Appointment of Ms. Shilpa Shah (Practising Company Secretary), as Secretarial Auditor for FY 2024-25, The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is attached as 'Annexure B'. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 04 Feb, 2025 | 14 Feb, 2025 |
| Stock Split | -- | 25 Jan, 2025 | 29 Jan, 2025 |
| Others | -- | 06 Jan, 2025 | 09 Jan, 2025 |
| Quarterly Results | -- | 08 Nov, 2024 | 14 Nov, 2024 |
| Rights issue of Equity Shares | -- | 25 Sept, 2024 | 28 Sept, 2024 |
| Quarterly Results | -- | 06 Aug, 2024 | 12 Aug, 2024 |
| Audited Results & Dividend | -- | 22 May, 2024 | 29 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 12 Feb, 2024 |
| Quarterly Results | -- | 30 Oct, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 12 Aug, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 50.96% | 50.96% | 49.17% | 49.17% | 49.17% |
| Foreign Institutions + | 0% | 0% | 0% | 0% | 0% |
| Domestic Institutions + | 0.11% | 0.11% | 0.8% | 0.8% | 0.8% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 48.93% | 48.93% | 50.03% | 50.03% | 50.03% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals is a Public Limited Listed company incorporated on 04/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1993PLC019079 and registration number is 019079. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 74.57 Cr. and Equity Capital is Rs. 10.95 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Dakshesh Rameshchandra Shah
NSE Symbol
--
Shukra Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Dakshesh Rameshchandra Shah | Managing Director |
| Mrs. Payal Sujay Mehta | Executive Director |
| Mr. Dhruvin Shah | Whole Time Director |
| Mr. Sanskruti Jayeshbhai Patel | Whole Time Director |
| Mrs. Anar Jayeshbhai Patel | Whole Time Director |
| Mrs. Bhoomiben Patel | Independent Director |
| Mrs. Sonal Deepalbhai Gandhi | Independent Director |
| Mr. Sarjeevan Singh Rathore | Independent Director |
| Mr. Jitendra Somchand Shah | Independent Director |
| Mrs. Pinki Nirmal Sagar | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,24,682.29 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,52,989.54 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,556.300 - ₹6,448.750 |
| Cipla | ₹1,20,795.29 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,09,916.93 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,00,161.69 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Shukra Pharmaceuticals
What is the share price of Shukra Pharmaceuticals?
The share price of Shukra Pharmaceuticals on 04 Apr, 2025 is ₹ 20.17.
What is 52W high and 52W low share price of Shukra Pharmaceuticals?
The highest and lowest 52W share prices of Shukra Pharmaceuticals are ₹ 27.150 and ₹ 5.750
What is the market cap of Shukra Pharmaceuticals?
The market capitalization of Shukra Pharmaceuticals as of 04 Apr, 2025 is ₹ 883.20 Crores
What is the P/E ratio of Shukra Pharmaceuticals?
The current P/E ratio of Shukra Pharmaceuticals as of 04 Apr, 2025 is 46.49
What is the PB ratio of Shukra Pharmaceuticals?
The PB ratio of Shukra Pharmaceuticals as of 04 Apr, 2025 is 0.38
Top Gainers
₹109.04
₹90.87 (0.20%)
₹75.34
₹62.79 (0.20%)
₹143.15
₹119.30 (0.20%)
₹3.81
₹3.18 (0.20%)
Top Losers
₹3,206.90
₹3,774.25 (-0.15%)
₹28.50
₹32.80 (-0.13%)
₹950.60
₹1,188.25 (-0.20%)
₹753.20
₹889.55 (-0.15%)
Market Indices
Sensex
₹76,295.36
₹76,617.44 (0.00%)